GENEVA, July 6 -- MOCHIDA PHARMACEUTICAL CO., LTD. filed a patent application (JP2025/045511) for “NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF IL-33”. With publication no. WO/2026/141544, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 15/113
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....